109 related articles for article (PubMed ID: 22489357)
1. Splenic lymphomas: is there still a role for splenectomy?
Martin P; Rutherford S; Leonard JP
Oncology (Williston Park); 2012 Feb; 26(2):204, 206. PubMed ID: 22489357
[No Abstract] [Full Text] [Related]
2. Marginal zone lymphomas: management of nodal, splenic, and MALT NHL.
Kahl B; Yang D
Hematology Am Soc Hematol Educ Program; 2008; ():359-64. PubMed ID: 19074110
[TBL] [Abstract][Full Text] [Related]
3. Clinical and biological diversity of splenic marginal zone lymphoma.
Matutes E
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1185-9. PubMed ID: 19761421
[No Abstract] [Full Text] [Related]
4. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
[TBL] [Abstract][Full Text] [Related]
5. Splenic marginal zone lymphoma associated with hepatitis B virus infection, remission after viral treatment, and splenectomy: A case report and review of the literature.
Ababou M; Mahtat EM; Jennane S; Elmaaroufi H; Mikdame M; Doghmi K
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):153-155. PubMed ID: 31306619
[TBL] [Abstract][Full Text] [Related]
6. Splenic marginal zone lymphoma: villous, not necessarily villainous.
Bociek RG
Oncology (Williston Park); 2012 Feb; 26(2):208, 210. PubMed ID: 22489358
[No Abstract] [Full Text] [Related]
7. Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
Xing KH; Kahlon A; Skinnider BF; Connors JM; Gascoyne RD; Sehn LH; Savage KJ; Slack GW; Shenkier TN; Klasa R; Gerrie AS; Villa D
Br J Haematol; 2015 May; 169(4):520-7. PubMed ID: 25854936
[TBL] [Abstract][Full Text] [Related]
8. Splenic marginal zone lymphoma: current knowledge and future directions.
Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
[TBL] [Abstract][Full Text] [Related]
9. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A
Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961
[TBL] [Abstract][Full Text] [Related]
10. Splenic marginal zone lymphoma in a patient with chronic hepatitis B.
Christou L; Kalambokis G; Bai M; Kamina S; Tsianos EV
J Gastrointestin Liver Dis; 2009 Dec; 18(4):511-2. PubMed ID: 20076834
[No Abstract] [Full Text] [Related]
11. Management of marginal zone lymphoma.
Reid R; Friedberg JW
Oncology (Williston Park); 2013 Sep; 27(9):840, 842, 844. PubMed ID: 24282977
[No Abstract] [Full Text] [Related]
12. Splenic marginal zone lymphoma in 5 dogs (2001-2008).
Stefanello D; Valenti P; Zini E; Comazzi S; Gelain ME; Roccabianca P; Avallone G; Caniatti M; Marconato L
J Vet Intern Med; 2011; 25(1):90-3. PubMed ID: 21092007
[TBL] [Abstract][Full Text] [Related]
13. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
Elmahy H; Hawley I; Beard J
Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
[TBL] [Abstract][Full Text] [Related]
14. [Splenic marginal zone lymphoma].
Dimopoulos K; Pedersen M
Ugeskr Laeger; 2012 Oct; 174(40):2383-6. PubMed ID: 23031300
[TBL] [Abstract][Full Text] [Related]
15. A Single-center Experience in Splenic Diffuse Red Pulp Lymphoma Diagnosis.
Julhakyan HL; Al-Radi LS; Moiseeva TN; Danishyan KI; Kovrigina AM; Glebova SM; Lugovskaya SA; Dvirnik VN; Khvastunova AN; Yakutik IA; Savchenko VG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S166-9. PubMed ID: 27131623
[TBL] [Abstract][Full Text] [Related]
16. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
[TBL] [Abstract][Full Text] [Related]
17. Splenic marginal zone lymphoma leads to sinistral portal hypertension.
Lv XH; Ma LL; Fu WY; Xie Y
J Dig Dis; 2019 Jan; 20(1):45-48. PubMed ID: 30549195
[No Abstract] [Full Text] [Related]
18. Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab.
Bennett M; Schechter GP
Semin Hematol; 2010 Apr; 47(2):143-7. PubMed ID: 20350661
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes with and without splenectomy in splenic marginal zone lymphoma.
Olszewski AJ
Am J Hematol; 2012 Nov; 87(11):E119-22. PubMed ID: 22887176
[TBL] [Abstract][Full Text] [Related]
20. Pseudo-faggot cells in splenic marginal zone lymphoma.
Wilson J
Br J Haematol; 2023 Apr; 201(1):7. PubMed ID: 36606572
[No Abstract] [Full Text] [Related]
[Next] [New Search]
